Refractory Coronary Stent Thrombosis in a Patient with Chronic Immune Thrombocytopenia on Eltrombopag

被引：0
|
作者：
Chen, Tse-Wei [1 ]
Huang, Ting-Chun [1 ,2 ]
Huang, Chen-Wei [1 ]
Liu, Ping-Yen [1 ,2 ]
机构：
[1] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Div Cardiol, Dept Internal Med, Tainan, Taiwan
[2] Natl Cheng Kung Univ, Inst Clin Med, Coll Med, Tainan, Taiwan
来源：
ACTA CARDIOLOGICA SINICA | 2021年 / 37卷 / 05期
关键词：
ITP;
D O I：
10.6515/AC5.202109_37(5).20210518A
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：542 / 545
页数：4
相关论文
共 50 条
  • [31] Eltrombopag in patients with chronic immune thrombocytopenia in Asia-Pacific, the Middle East, and Turkey: final analysis of CITE
    Wong, Raymond Siu Ming
    Yavasoglu, Irfan
    Yassin, Mohamed A.
    Tarkun, Pinar
    Yoon, Sung -Soo
    Wei, Xie
    Elghandour, Ashraf
    Angchaisuksiri, Pantep
    Ozcan, Mehmet
    Yang, Renchi
    Mattar, Mervat
    Rahman, Masiur
    Ingles, Sara
    Goldbrunner, Michael
    Frueh, Jennifer A.
    Jang, Jun Ho
    BLOOD ADVANCES, 2023, 7 (17) : 4773 - 4781
  • [32] Pediatric immune thrombocytopenia: a focus on eltrombopag as second-line therapy
    Palumbo, Giuseppe
    Farruggia, Piero
    Ramenghi, Ugo
    Russo, Giovanna
    Borchiellini, Alessandra
    Spinelli, Marco
    Dufour, Carlo
    Giona, Fiorina
    Ladogana, Saverio
    Zecca, Marco
    Perrotta, Silverio
    Pession, Andrea
    Giordano, Paola
    HEMATOLOGY, 2023, 28 (01)
  • [33] Modeling and Simulation Support Eltrombopag Dosing in Pediatric Patients With Immune Thrombocytopenia
    Wire, Mary B.
    Li, Xiaobin
    Zhang, Jianping
    Sallas, William
    Aslanis, Vassilios
    Ouatas, Taoufik
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (06) : 1199 - 1207
  • [34] Romiplostim overcomes refractory secondary immune thrombocytopenia in a patient affected by serous ovarian carcinoma
    Baldini, Simone
    Fambrini, Massimiliano
    Carrai, Valentina
    Rigacci, Luigi
    Alterini, Renato
    Bosi, Alberto
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2012, 1 (04): : 239 - 242
  • [35] Romiplostim overcomes refractory secondary immune thrombocytopenia in a patient affected by serous ovarian carcinoma
    Simone Baldini
    Massimiliano Fambrini
    Valentina Carrai
    Luigi Rigacci
    Renato Alterini
    Alberto Bosi
    International Cancer Conference Journal, 2012, 1 (4) : 239 - 242
  • [36] Spleen tyrosine kinase inhibition: a new promising approach to chronic and refractory immune thrombocytopenia
    Niscola, Pasquale
    Scaramucci, Laura
    Giovannini, Marco
    IMMUNOTHERAPY, 2018, 10 (01) : 5 - 7
  • [37] Effect of Cytokine Gene Polymorphisms on Eltrombopag Reactivity in Japanese Patients with Immune Thrombocytopenia
    Nomura, Shosaku
    Abe, Misao
    Yamaoka, Manabu
    Ito, Tomoki
    JOURNAL OF BLOOD MEDICINE, 2021, 12 : 421 - 429
  • [38] B cells and antibodies in refractory immune thrombocytopenia
    Roeser, Anais
    Lazarus, Alan H.
    Mahevas, Matthieu
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 203 (01) : 43 - 53
  • [39] Pediatric refractory immune thrombocytopenia: A systematic review
    Ibrahim, Layan
    Dong, Selina X.
    O'Hearn, Katie
    Grimes, Amanda B.
    Kaicker, Shipra
    FritchLilla, Stephanie
    Breakey, Vicky R.
    Grace, Rachael F.
    Lebensburger, Jeffrey D.
    Klaassen, Robert J.
    Lambert, Michele
    PEDIATRIC BLOOD & CANCER, 2023, 70 (03)
  • [40] Sustained response off treatment in eltrombopag for children with persistent/chronic primary immune thrombocytopenia: A multicentre observational retrospective study in China
    Wang, Zhifa
    Wang, Lijuan
    Liu, Yan
    Meng, Jinxi
    Dong, Shuyue
    Ma, Jingyao
    Hu, Yu
    Chen, Zhenping
    Cheng, Xiaoling
    Wu, Runhui
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 202 (02) : 422 - 428
12345